不规则抗体筛查在临床输血治疗患者中应用探讨

摘要

Objective:To investigate application value of irregular antibody screening in clinical blood transfusion. Methods:1 000 patients with blood transfusion were used as the research object, and the irregular antibody screening before blood transfusion treatment was done. Results:In this group of 1 000 patients, the results showed that 21 cases were positive with a positive rate of 0. 21%, wherein 10 cases (0. 10%) were anti E, 5 cases (0. 05%) were anti M4, 3 cases (0. 02%) were anti D2, 2 cases (0. 02%) were autoimmune antibody, and 1 case (0. 01%) was cold antibody. 21 cases had no hemolytic transfusion reaction. Con-clusions:The application of irregular antibody screening in clinical blood transfusion can actively prevent the occurrence of hemolytic transfusion reaction.%目的：：探讨不规则抗体筛查在临床输血治疗患者中的应用价值。方法：随机抽取接受输血治疗的1000例患者为研究对象,在输血治疗前均行不规则抗体筛查。结果：①接受输血治疗的1000例患者中不规则抗体阳性21例,阳性率为0.21％,其中10例(0.10％)为抗E,5例(0.05％)为抗M4,3例(0.03％)为抗D2,2例(0.02％)为自身免疫性抗体,1例(0.01％)为冷抗体；②21例不规则抗体阳性患者均未发生溶血性输血反应。结论：在临床输血治疗患者中应用不规则抗体筛查,可积极预防患者溶血性输血反应的发生。